Workflow
InnovAge (INNV)
icon
Search documents
InnovAge (INNV) - 2023 Q2 - Quarterly Report
2023-02-07 22:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (S ...
InnovAge (INNV) - 2023 Q1 - Earnings Call Transcript
2022-11-12 03:58
InnovAge Holding Corp. (NASDAQ:INNV) Q1 2023 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Ryan Kubota - Director of IR Patrick Blair - President and CEO Barbara Gutierrez - CFO Rich Feifer - Chief Medical Officer Conference Call Participants Calvin Sternick - JPMorgan Madeline Mollman - William Blair Jason Cassorla - Citi Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the InnovAge First Quarter 2023 Earnings Conference Call. [Operator Instruct ...
InnovAge (INNV) - 2023 Q1 - Quarterly Report
2022-11-08 22:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (State or Other Jurisdiction of Inc ...
InnovAge (INNV) - 2022 Q4 - Earnings Call Transcript
2022-09-14 01:42
InnovAge Holding Corp. (NASDAQ:INNV) Q4 2022 Results Conference Call September 13, 2022 5:00 PM ET Company Participants Ryan Kubota - IR Patrick Blair - President and CEO Barbara Gutierrez - CFO Rich Feifer - Chief Medical Officer Conference Call Participants Jason Cassorla - Citigroup Sarah James - Barclays Jamie Perse - Goldman Sachs Madeline Mollman - William Blair Operator Good day and thank you for standing by. Welcome to the InnovAge Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions ...
InnovAge (INNV) - 2022 Q4 - Annual Report
2022-09-13 21:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (State or Othe ...
InnovAge (INNV) - 2022 Q3 - Earnings Call Transcript
2022-05-15 04:40
InnovAge Holding Corp. (NASDAQ:INNV) Q3 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Ryan Kubota - Director, Investor Relations Patrick Blair - President and Chief Executive Officer Barbara Gutierrez - Chief Financial Officer Melissa Welch - Chief Medical Officer Conference Call Participants Jeff Garro - Piper Sandler Sarah James - Barclays Jamie Perse - Goldman Sachs Matt Larew - William Blair Andrew Lothian - JPMorgan Operator Good day and thank you for standing by and welcom ...
InnovAge (INNV) - 2022 Q3 - Quarterly Report
2022-05-10 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (Stat ...
InnovAge (INNV) - 2022 Q2 - Earnings Call Transcript
2022-02-10 02:14
InnovAge Holding Corp. (NASDAQ:INNV) Q2 2022 Results Conference Call February 9, 2022 5:00 PM ET Company Participants Ryan Kubota - Director, IR Patrick Blair - President and CEO Barb Gutierrez - CFO Dr. Melissa Welch - Chief Medical Officer Conference Call Participants Jason Cassorla - Citi Sarah James - Barclays Jeff Garro - Piper Sandler Lisa Gill - JP Morgan Jamie Perse - Goldman Sachs Gary Taylor - Cowen Matt Larew - William Blair Operator Good day and thank you for standing by. Welcome to the InnovAge ...
InnovAge (INNV) - 2022 Q2 - Quarterly Report
2022-02-09 22:29
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (S ...
InnovAge (INNV) - 2022 Q1 - Earnings Call Transcript
2021-11-13 17:58
InnovAge Holding Corp (NASDAQ:INNV) Q1 2022 Earnings Conference Call November 9, 2021 5:17 PM ET Company Participants Ryan Kubota - Director of Investor Relations Maureen Hewitt - President and Chief Executive Officer Barb Gutierrez - Chief Financial Officer Melissa Welch - Chief Medical Officer Conference Call Participants Vikram Kesavabhotla - Baird Melissa Welch - Chief Medical Officer Jason Cassorla - Citi Matt Larew - William Blair Jamie Perse - Goldman Sachs Sarah James - Barclays Jeff Garro - ...